Crowdonomics
BIOSMART RESEARCH, INC.

Reg CF · Convertible Note · Jun 2021

ClosedReached targetReg CFConvertible Note
via WeFunderView campaign
Raised
$53.4K / $1.1M max
5% of ceiling · target hit day 63
Investors
24
$2.2K avg
Valuation cap
$15M
cap, not an agreed valuation

Raised over time

Cumulative raisedInvestors
$53K$27K$0
1680
Jun 29, 2021 · openedDec 22, 2021 · last reading
Target ($50K) hit — Aug 31, 2021, day 63Deadline Apr 30, 2022 — 129 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2019–FY2020 · hover for source
$1.9M
$75K
FY2019
$53K
−$149K
FY2020
RevenueNet income
Metric
FY2019 reviewed
FY2020 reviewed
Income statement
Revenue
$1,873,578
$52,952
Cost of goods sold
$1,497,859
$0
Gross margin
20%
100%
Net income
$74,730
-$149,247
Taxes paid
$0
$0
Balance sheet
Cash
$68,970
$49,777
Accounts receivable
$0
$0
Total assets
$2,472,260
$2,627,387
Short-term debt
$2,314
$113,067
Long-term debt
$112,577
$127,210
Total liabilities
$114,891
$240,277
Other
Headcount
—
5

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Valuation cap$15M
Conversion discount20%
Interest rate6%

Perks

First $250K will invest in a convertible not with a $15M valuation capfirst $250K

Offering details

Target$50,000
Max$1,070,000
Min investment$100
OpenedJun 29, 2021
DeadlineApr 30, 2022
ClosedDec 22, 2021
Days active176

Links & provenance

Source: Manual
0001670254-21-000764

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.